featured
Relapses Reduced With Adjuvant Lymph–Node Field RT in Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Lymph-Node Field Radiotherapy Versus Observation Only in Patients With Melanoma at High Risk of Further Lymph-Node Field Relapse After Lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-Year Follow-Up of a Phase 3, Randomized Controlled Trial
Lancet Oncol 2015 Jul 20;[EPub Ahead of Print], MA Henderson, BH Burmeister, J Ainslie, R Fisher, J Di Iulio, BM Smithers, A Hong, K Shannon, RA Scolyer, S Carruthers, BJ Coventry, S Babington, J Duprat, HJ Hoekstra, JF ThompsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.